Clinical Trial Update: Extended Endocrine Therapy for Premenopausal Women With Breast Cancer [Phase 2]

View source ↗

Summary

This entry reports results from a Phase 2 trial evaluating extended endocrine therapy in premenopausal women with breast cancer. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-04